myMatrixx Chief Clinical Officer Phil Walls joined John Ruser, PhD, President and CEO of the Workers’ Compensation Research Institute for an on-demand webinar available starting today, June 24, on the Risk & Insurance website. The presentation, Key Factors that Are Impacting Pharmaceutical Spend in Workers’ Compensation, covers ongoing and emerging trends in the industry, including data and analysis from the 2020 myMatrixx Drug Trend Report. Both experts engaged in an in-depth discussion, moderated by Dan Reynolds, Editor-in-Chief for Risk & Insurance, that helps bring clarity to the current landscape and helps claims professionals and other stakeholders develop effective claims strategies.
Topics covered include the “COVID Distortion Effect,” uncovered by the myMatrixx and Express Scripts clinical pharmacy teams and discussed in the Drug Trend Report. A pandemic-related dropoff in newer claims, which typically have lower utilization and spending, caused the appearance of an increase in overall utilization and spend. In the presentation, Walls and Ruser will discuss the need to account for this trend and the potential effects it could have on pharmacy data moving forward. Other topics will include the effect of the pandemic on opioid use and misuse, the continuing rise of specialty drug utilization and the growing issue of subtherapeutic dosing for certain drugs.